BFM Business « Le Tête à Tête Décideurs » – Interview de Jacky Vonderscher, DG d’ENYO Pharma

https://bfmbusiness.bfmtv.com/le-tete-a-tete-decideurs/utiliser-les-virus-pour-decouvrir-de-nouveaux-medicaments-1421334.html

Published on 17/04/2018

2018 BIO International Convention

4-7 June, 2018

Boston, USA

“The BIO International Convention is hosted by the Biotechnology Innovation Organization, which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products”.

http://convention.bio.org/2018/

Read more »

Published on 03/04/2018

GHP – Most Innovative Drug Discovery Company – West Europe & Award for Excellence in Mitochondrial Disease Drug Development

https://www.ghp-news.com/issues/biotechnology-awards-2018/20/

Published on 26/03/2018

USA allowance for the FXR agonist use patent in HBV

ENYO Pharma got the USA allowance for its FXR agonist use patent in hepatitis B virus (HBV). The patent was licensed under exclusive agreement from Inserm. FXR agonists change the composition of the transcriptional complex on the HBV cccDNA resulting in repression of HBV cccDNA expression.

Read more »

Published on 13/03/2018

BioCentury – Management tracks: Sotio, Epimab

https://www.biocentury.com/bc-extra/company-news/2018-02-27/management-tracks-sotio-epimab

Published on 05/03/2018